Latest McLean Hospital Stories
BOSTON, Jan. 10, 2014 /PRNewswire/ -- The National Institute of Mental Health has prioritized the development of a rapidly acting treatment for depression as a key research goal.
Belief in God may significantly improve the outcome of those receiving short-term treatment for psychiatric illness.
The long-term use of anabolic-androgenic steroids (AAS) may severely impact the user's ability to accurately recall the shapes and spatial relationships of objects.
According to a new study published in the current issue of Drug and Alcohol Dependence, an extract of the Chinese herb kudzu reduces binge drinking and could be useful in the treatment of alcoholism.
Individuals addicted to prescription painkillers are more likely to succeed in treatment with the aid of the medication buprenorphine-naloxone (Suboxone).
Researchers at Harvard-affiliated McLean Hospital have found that those who believe in a benevolent God tend to worry less and be more tolerant of life's uncertainties than those who believe in an indifferent or punishing God.
Ecstasy use does not impair a person's cognitive function or diminish their mental ability, according to a new study published Tuesday in the journal Addiction.
US researchers are getting closer to having an accurate test for autism, a finding that could lead to earlier diagnosis and treatment.
Researchers at Harvard-affiliated McLean Hospital have produced the first evidence that the opioid blocker extended-release injectable naltrexone (XR-NTX) is able to reduce the brain's response to cues that may cause alcoholics to relapse.
Researchers are baffled to find indications that women have more of an issue with looking at babies with facial birth defects than men.